Edmond de Rothschild Group
Edmond de Rothschild is a prominent financial services group based in Geneva, Switzerland, founded in 1953. The group specializes in wealth management, offering a comprehensive range of services that include private banking, asset management, private equity, and corporate finance. Its private equity division focuses on growth capital investments, particularly in emerging markets and infrastructure, while also emphasizing environmental, social, and governance (ESG) factors in its investment strategies. The group actively manages assets across various sectors, including real estate, agriculture, and transportation, and provides advisory services in mergers and acquisitions. With a firm commitment to collaboration, Edmond de Rothschild positions itself as a partner in growth for its clients, leveraging its expertise to create value across its diverse portfolio.
Genkyotex SA is a biopharmaceutical company based in Labège, France, focusing on the development of innovative oral small molecule therapies that selectively inhibit NOX enzymes implicated in various disease processes. The company's lead candidate, GKT831, is a NOX1 and NOX4 inhibitor undergoing Phase II clinical trials for primary biliary cholangitis, a fibrotic orphan disease, and type 1 diabetes with kidney complications. In addition, Genkyotex is advancing GKT771, a preclinical NOX1 inhibitor aimed at addressing pain processing and inflammation. The company also holds a license agreement with Serum Institute of India Ltd. for GTL003, an antigen for developing multivalent combination vaccines against infectious diseases. Genkyotex's technology is designed to treat oxygen-radical mediated acute and chronic diseases, offering improved specificity and safety compared to existing antioxidant therapies, and targets cardiovascular, metabolic, and neurodegenerative conditions. Founded in 2006, Genkyotex is committed to enhancing patient outcomes through its research and development initiatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.